Skip to main content

Benign Lesions

  • Chapter
  • First Online:
  • 436 Accesses

Abstract

Benign breast lesions deserve attention because of their high prevalence. Breast cancer is the most common malignancy in women in developed countries; however, the vast majority of lesions that occur in the breasts are benign. The majority of patients, who present with a clinical breast problem, usually have a benign lesion. Diagnosis of a benign disease of the breast is usually accomplished with mammography, ultrasound (US), magnetic resonance imaging (MRI) or needle biopsies, thereby eliminating the need for surgery [1–3].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Guray M, Sahin A. Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006;11(5):435–49.

    Article  Google Scholar 

  2. Putti TC, Pinder SE, et al. Breast pathology practice: most common problems in a consultation service. Histopathology. 2005;47:445–57.

    Article  CAS  Google Scholar 

  3. Miltenburg DM, Speigths VO Jr. Benign breast disease. Obstet Gynecol Clin North Am. 2008;35:285–300.

    Article  Google Scholar 

  4. Neal L, Tortorelli CL, et al. Clinician’s guide to imaging and pathologic findings in benign breast disease. Mayo Clin Proc. 2010;85:274–9.

    Article  Google Scholar 

  5. Pearlman MD, Griffin JL. Benign breast disease. Obstet Gynecol. 2010;116:747–58.

    Article  Google Scholar 

  6. Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005;353:275–85.

    Article  CAS  Google Scholar 

  7. Goehring C, Morabia A. Epidemiol Rev. 1997;19:310–27.

    Article  CAS  Google Scholar 

  8. Runruang B, Kelleym J. Benign breast diseases: epidemiology, evaluation and management. Clin Obstet Gynecol. 2011;54:110–24.

    Article  Google Scholar 

  9. Hartmann LC, Sellers TA, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229–37.

    Article  CAS  Google Scholar 

  10. Bartow SA, Pathak DR, Black WC, et al. Prevalence of benign, atypical and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer. 1987;60:2751–60.

    Article  CAS  Google Scholar 

  11. Smith A. The principles of contrast mammography. Info@hologic.com.

    Google Scholar 

  12. Lobbes MB, Smidt ML, et al. Contrast enhanced mammography: techniques, current results, and potential indications. Clin Radiol. 2013;68:935–44.

    Article  CAS  Google Scholar 

  13. Diekmann F, Freyer M, et al. Evaluation of contrast enhanced digital mammography. Eur J Radiol. 2011;78:112–21.

    Article  Google Scholar 

  14. Kamal R, Helal M, et al. Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography? Br J Radiol. 2016;89(1064):20160157.

    Article  Google Scholar 

  15. Jochelson MS, Dershaw DD, Sung JS, et al. Bilateral contrast enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MRI imaging in women with known breast carcinoma. Radiology. 2013;266:743–51.

    Article  Google Scholar 

  16. Dupont WD, Page DL. Risk factors for breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71:1258–65.

    Article  CAS  Google Scholar 

  17. Orr B, Kelley JL III. Benign breast diseases: evaluation and management. Clinical Obstet Gynecol. 2016;59(4):710–26.

    Article  Google Scholar 

  18. Goel NB, Knight TE, et al. Fibrous lesions of the breast: imaging-pathologic correlation. Radiographics. 2005;25:1547–59.

    Article  Google Scholar 

  19. Dupont WD, Dl P, et al. Long term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994;331:10–5.

    Article  CAS  Google Scholar 

  20. Houssami N, Irwig L, Ung O. Review of complex breast cysts: implications for cancer detection and clinical practice. ANZ J Surg. 2005;75:1080–5.

    Article  Google Scholar 

  21. Venta LA, Kim JP, Pelloski CE, et al. Management of complex breast cysts. AJR Am J Roentgenol. 1999;173:1331–6.

    Article  CAS  Google Scholar 

  22. Jensen RA, Page DL, Dupont WD, et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer. 1989;64:1977–83.

    Article  CAS  Google Scholar 

  23. London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267:941–4.

    Article  CAS  Google Scholar 

  24. Hines N, Slanetz PJ, et al. Cystic masses of the breast. AJR. 2010;194:W122–33.

    Article  Google Scholar 

  25. Chen J, Nalcioglu O, et al. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging. 2008;28(6):1499–505.

    Article  Google Scholar 

  26. Chen J, Liu H, et al. MR imaging features of fibrocystic change of the breast. Magn Reson Imaging. 2008;26(9):1207–14.

    Article  Google Scholar 

  27. Tse GM, Law BK, et al. Hamartoma of the breast: a clinical pathological review. J Clin Pathol. 2002;55:951–4.

    Article  CAS  Google Scholar 

  28. Linda A, Zuiani C, et al. The wide spectrum of hyperechoic lesions of the breast. Clin Radiol. 2011;66:559–65.

    Article  CAS  Google Scholar 

  29. Linda A, Zuini C, Lorenzon M, et al. Hyperechoic lesions of the breast: not always benign. AJR Am J Roentgenol. 2011;196:1219–24.

    Article  Google Scholar 

  30. Adrada B, Wu Y, Yang W. Hyperechoic lesions of the breast: radiologic-histopathologic correlation. AJR Am J Roentgenol. 2013;200:W518–30.

    Article  Google Scholar 

  31. Presazzi A, Di Giulio G, et al. Breast hamartoma: ultrasound, elastosonographic, and mammographic features. Mini pictorial essay. J Ultrasound. 2015;18:373–7.

    Article  CAS  Google Scholar 

  32. Knogler T, Homolka P, et al. Application of BI-RADS descriptors in contrast enhanced dual-energy mammography: comparison with MRI. Breast Care. 2017;12:212–6.

    Article  Google Scholar 

  33. Tuffarelli M, Pellegrini A, et al. Positive predictive value of brast lesions of uncertain malignant potential (B3): Can we identify high risk patients? The value of a multidisciplinary team and implications in the surgical treatment. Surg Oncol. 2016;25:119–22.

    Article  Google Scholar 

  34. Rakha EA, Ho BC, et al. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detaile review of epithelial atypia. Histopathology. 2011;56:626–32.

    Article  Google Scholar 

  35. Rageth CJ, O’Flynn EAM, et al. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 2016;159:203–2013.

    Article  Google Scholar 

  36. Eiada R, Chong J, et al. Papillary lesions of the breast: MRI, ultrasound, and mammographic appearances. AJR Am J Roentgenol. 2012;198:264–71.

    Article  Google Scholar 

  37. Tan PH, Lai LM, et al. Fat necrosis of the breast: a review. Breast. 2006;15:313–8.

    Article  CAS  Google Scholar 

  38. Taboada J, Stephens T, et al. The many faces of fat necrosis in the breast. AJR Am J Roentgenol. 2009;192:815–25.

    Article  Google Scholar 

  39. Dromain C, Thibault F, Diekmann F, et al. Dual energy contrast-enhanced digital mammography: initial clinical result of a multireader, multicase study. Breast cancer Res. 2012;14:R94.

    Article  Google Scholar 

  40. Luczynka E, Heinze-Paluchowska S, et al. Contrast enhanced spectral mammography: comparison with conventional mammography and histopathology in 152 women. Korean J Radiol. 2014;15:689–96.

    Article  Google Scholar 

  41. Luczynka E, Niemiec J, et al. Degree of enhancement on contrast enhanced spectral mammography (CESM) and lesion type on mammography (MG): comparison based on histological results. Med Sci Monit. 2016;22:3886–93.

    Article  Google Scholar 

  42. Covington MF, Pizzitola VJ, et al. The future of contrast enhanced mammography. AJR Am J Roentgenol. 2018;210:1–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vanzi, E., Di Naro, F., Bellini, C. (2018). Benign Lesions. In: Nori, J., Kaur, M. (eds) Contrast-Enhanced Digital Mammography (CEDM). Springer, Cham. https://doi.org/10.1007/978-3-319-94553-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94553-8_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94552-1

  • Online ISBN: 978-3-319-94553-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics